Urologiia
Peer-review scientific medical journal
Editor-in-chief
-
professor Yury G. Alyaev, MD, corresponding member of Russian Academy of Sciences
http://uro-andro.ru/specialists/alyaev-yurii-gennadevich
http://www.ncbi.nlm.nih.gov/pubmed/?term=Aljaev&cmd=DetailsSearch
http://www.ncbi.nlm.nih.gov/pubmed/?term=AliaevScopus ID: 6603248335
Publisher
-
LLC “Bionika Media”
Founders
-
Russian Society Urology
-
First Sechenov Moscow State Medical University
WEB official
Aims and Scope
Urologia (Urology) is a scientific peer-reviewed medical journal that aims to publish quality articles highlighting the latest achievements in the field of urology, andrology, nephrology and urologic oncology. In accordance with this goal, we publish timely, practical, and state-of-the-art contributions on clinical research and experience in the relevant field. The Journal encompasses all aspects of basic urological research, etiology, pathogenesis, advanced methods of diagnosis, prevention and treatment of genitourinary system diseases, inflammation of various etiologies, urolithiasis, renal insufficiency, reconstructive surgery, andrology and pediatric urology.
The audience is primarily urologists, andrologists, nephrologists, surgeons, obstetricians, pediatricians, general practitioners, medical researchers.
The Journal is indexed in Web of Science, Medline, Scopus, Pub Med, Biological Abstracts, Chemical Abstracts, Excerpta Medica, Index Medicus.
Being an invaluable source of both basic science and clinical research, the Journal "Urology" is best known for its contribution to the education of many generations of Russian scientific and medical professionals. Publication in this journal has become an important measure of scientific and practical significance for the vast majority of doctoral and master's dissertations.
Since 2012 the Journal has been published by Bionika Media Publishing House.
Bionika Media Publishing House seeks to comply with the ethical standards at all stages, ensuring that publication process conforms to the International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf).
Our Primary Objectives
-
Publish high-quality research papers that meet international standards of scientific publications;
-
Further improve the general quality of reviewing and editing of manuscripts submitted for publication;
-
Provide a widest possible dissemination of the published articles among the global scientific community;
-
Extend distribution and indexing of scientific publications in key international citation bases.
Current Issue



No 3 (2025)
Original Articles
Functional outcomes of surgical treatment of patients with benign prostatic hyperplasia
Abstract
Aim. To compare the functional outcomes of various surgical procedures, to assess the rate of complications and urination disorders after surgery, and to identify possible risk factors and predictors of unsatisfactory treatment outcomes.
Materials and methods. The functional outcomes of surgical treatment were evaluated in 398 patients with benign prostatic hyperplasia (BPH). Patients were divided into 3 groups depending on the surgical method: bipolar transurethral resection of the prostate, laser enucleation of the prostate, and laparoscopic simple prostatectomy. The groups were comparable in age, comorbidities, and maximum urinary flow rate (Qmax). Prostate volume, total PSA level, and IPSS score differed between groups. They were higher in the group of simple prostatectomy.
Results. Before surgical treatment, 192 (48.2%) patients underwent urodynamic studies including "filling cystometry" and "pressure-flow", to determine the bladder outlet obstruction index (BOOI) and detrusor overactivity (DO), which was confirmed in 82.8% of cases. The mean BOOI value was 72.1.
Functional outcomes did not statistically differ between groups at all follow-up points during the first year. After 12 months, the mean Qmax across all groups was 22.3±6.4 ml/s, the median IPSS value after the transurethral resection and simple prostatectomy was 3.0 points, while in the enucleation group it was 4.0 points.
Transient urinary incontinence after catheter removal was recorded in 46 (11.6%) patients. By 3 months of follow-up, 10 (2.5%) patients had urge urinary incontinence on urodynamic study, requiring conservative therapy with M-anticholinergics or β3-adrenomimetics. De novo stress urinary incontinence was confirmed in 1 (0.3%) patient after transurethral enucleation.
Infectious complications (prostatitis, orchiepididymitis) requiring antibiotic therapy occurred in 61 (15.3%) patients. The risk of infectious complications was higher in those with longer operative time (p=0.004), diabetes mellitus (p=0.006), and bacteriuria (p=0.019).
All strictures were identified after transurethral procedures, including transurethral resection (1.1%) and transurethral enucleation (6.8%). Patients with urethral strictures more often developed postoperative infectious complications (p=0.008). It was noted that patients with cystostomy tube had a lower frequency of strictures (p=0.076).



Efficacy and safety of minimally invasive injection steam therapy for lower urinary tract symptoms caused by benign prostate hyperplasia (first clinical experience in the Russian Federation)
Abstract
Introduction. Currently, the development of new methods of treatment of benign prostatic hyperplasia (BPH) is continuing, combining the high efficiency of transurethral resection of the prostate, which are safer for elderly patients and provide a high level of quality of life for younger patients. One of these new methods is minimally invasive water vapor thermal therapy.
Aim. To evaluate the efficiency and safety of water vapor thermal therapy in patients with lower urinary tract symptoms (LUTS)/BPH.
Materials and methods. A total of 35 patients with LUTS/BPH who were treated between September 2022 and September 2024 (median follow-up of 12 months) were included in the study. The average age was 68.7±1.5 years. The prostate volume did not exceed 80 cc (52.4±4.2 cc). The Qmax was 9.3±0.7 ml/sec. The postvoid residual volume (PVR) was 73.6±12.2 ml. The overall IPSS score was 26.5±2.3 and QoL was 4.3±0.3. All patients were treated with water vapor thermal therapy according to the standard procedure recommended by the manufacturer (5.7±0.72 injections of water vapor into the prostate). The efficacy was evaluated every 3 months after the procedure. Intra- and postoperative complications were assessed on Clavien-Dindo classification.
Results. After 3 months, 97.1% (34 out of 35) of patients had an improvement in objective urination parameters. Qmax and PVR after 3 months increased up to 17.3±1.5 ml/sec and 20.8±7.2 ml, respectively (p<0.05 compared with baseline values). There was also a significant decrease in IPSS and QoL levels, 8,5±1,3 and 2,3±0,3, respectively (p<0,05 compared with the baseline). Qmax and PVR continued to improve till the 6 months of follow-up (17.6±1.1ml/sec and 14.3±0.8 ml, respectively, p<0.05 compared with baseline and after 3 months). There was also a significant decrease in IPSS and QoL to 4.1±1.3 and 1.4±0.1 points, respectively (p<0.05 compared to 3 months). After that, these values remained stable throughout the follow-up period. The overall efficiency of the treatment (at median follow-up of 12 months) was 88,6%. Perioperative complications occurred in 9 out of 35 patients (did not exceed IIIa according to Clavien-Dindo).
Conclusions. Minimally invasive water vapor thermal therapy is a new effective and safe method of treating patients with LUTS/BPH. After the procedure, there is a significant improvement in lower urinary tract symptoms.



Transurethral augmentation repair for stricture of fossa navicularis
Abstract
A stricture of fossa navicularis is a significant challenge due to the complexity of surgical reconstruction which should provide good aesthetic and functional outcomes.
Aim. To evaluate the efficiency and safety of transurethral ventral augmentation urethroplasty in men with stricture of fossa navicularis.
Materials and methods. A prospective study of treatment outcomes of 9 patients with stricture of fossa navicularis who were admitted at V.M. Buyanov City Clinical Hospital from 2021 to 2024, was carried out. The inclusion criterion was the presence of an isolated urethral narrowing in the fossa navicularis, which was urodynamically significant. All patients underwent transurethral ventral urethrotomy of the narrowed segment using a lance scalpel with optical control of the depth of incision. Subsequently, a triangular oral mucosa graft was harvested and fixed using the “inlay” technique with 4 deep sutures (monocryl 4-0) in and 5 sutures along the ventral semicircle of the meatus. The urethral catheter was removed on days 12-14 in order to restore spontaneous voiding.
Results. The mean age of patients was 63.4 years. The follow-up period ranged from 6 to 38 months. The etiology was balanitis xerotica obliterans (BXO) in 5 cases, unknown in 2, and iatrogenic stricture in 2 patients. Labial mucosa was used as a graft in 6 men, and buccal mucosa in 3 cases. No intra- or postoperative complications were observed. Preoperatively, average maximum urine flow rate was 5.8 ml/sec, IPSS score 20.5 points. After surgical treatment, the average Qmax was 15 ml/sec, and the IPSS score was 13. No patient reported urine splashing.
Discussion. All patients experienced the satisfaction with both functional and aesthetic outcomes. The surgeon's subjective assessment of the convenience and the cosmetic result of using labial and buccal grafts favored labial mucosa. It seems to be preferable both due to the lesser thickness of the graft, which facilitates the technical manipulations, and in terms of preserving the buccal mucosa in patients with BXO for possible subsequent reconstructions.
Conclusions. The transurethral augmentation repair using oral mucosa is an effective and safe method for treatment of stricture of fossa navicularis.



Minimally invasive enucleation of the prostate (MILEP) with thulium fiber laser: preliminary results
Abstract
Introduction. Endoscopic enucleation of the prostate is the standard surgical treatment for patients with BPH >80 cc. Despite its efficiency, the incidence of stress urinary incontinence (<6 months) and urethral stricture remains significant at 16.6–29.4% and 1.7–6.5%, respectively. The use of smaller instruments can potentially reduce the rates of these complications.
Aim. This study aims to evaluate the efficiency and safety of minimally invasive laser enucleation of the prostate (MiLEP) using a thulium fiber laser (TFL).
Materials and methods. A prospective study was initiated in March 2024. The inclusion criteria were severe lower urinary tract symptoms (IPSS >20) and/or Qmax <15 ml/s or the necessity for bladder drainage. MiLEP was performed using 22 Ch resectoscope and TFL FIBERLASE U1 and FIBERLASE U-MAX (NTO IRE-Polus, Russia) with the following settings: 1.5 J and 50–55 Hz and 1.7–2 J and 40–45 Hz (DissectPulse). MiLEP technique was en bloc no-touch enucleation with early apical release. Peri- and early postoperative outcomes and complication rates were assessed.
Results. MiLEP was performed in 15 patients with a median age of 67 years (IQR 62.5; 69.5), prostate volume of 61 cc (IQR 46.5; 65.5), and IPSS score was 25.5 (IQR 23.3; 27), Qmax was 5.3 ml/s (IQR 4.5; 9.3). The median duration of the procedure was 42 min (IQR 37; 55), enucleation was 25 min (IQR 21; 28), and morcellation was 7.5 min (IQR 4; 8). Enucleation efficiency was 1.2 g/min (IQR 1; 1.5) and morcellation efficiency was 5.3 g/min (IQR 4.6; 7.7). The median hemoglobin drop was 6.5 g/l (IQR 1.5; 12.8) and the mass of removed tissue was 34 g (IQR 25; 42). The median catheterization and hospitalization time were 2 days (IQR 2; 2.8) and 3 days (IQR 3; 6), respectively. After 1 month, the median IPSS score was 5 (IQR 4; 6; р < 0.001), Qmax was 18.7 ml/s (IQR 18; 21; р < 0.001). Complications were observed in 5 (33.3%) patients (grade I according to Clavien-Dindo). Stress urinary incontinence occurred in 2 (13.3%) patients on the first day after catheter removal, but in none at 1 month after MiLEP.
Conclusion. Minimally invasive enucleation of the prostate with a thulium fiber laser can be considered an effective and safe surgical treatment option for patients with BPH.



Epidemiology of the distribution of “pure” and mixed uric acid stones in the Novosibirsk region
Abstract
Introduction. According to international studies, the prevalence of uric acid stones in 2023 was 8-10% worldwide. Uric acid stones are considered high-risk for symptomatic recurrence. Uric acid constitutes a frequent component of urinary calculi and may promote calcium oxalate stone formation.
Aim. To assess the prevalence of “pure” and mixed uric acid and urate salt stones among urinary calculi in the Novosibirsk Region.
Materials and methods. We evaluated 987 urinary stones from patients with urolithiasis in the Novosibirsk Region. Data for the period 2020–2023 were provided in anonymized form by INVITRO laboratory. We determined the prevalence of single-component and mixed urinary stones containing uric acid and its salts, alone or in combination with other minerals, stratified by sex and age.
Results. Uric acid stones were identified in 119 cases (80 men, 39 women), accounting for 12.06% of all analyzed stones. Pure uric acid stones presented as anhydrous uric acid in 1 case and as uric acid dihydrate in 4 cases. The majority (n=114) were mixed stones of anhydrous uric acid and uric acid dihydrate. Uric acid stones occurred nearly twice as often in men as in women (80 vs. 39). The prevalence of uric acid stones was highest in men aged 31–70 years and in women aged 41–70 years, declining thereafter in both sexes.
Mixed uric acid/urate stones (ammonium urate, sodium urate) were found in 15 patients (10 men, 5 women), representing 1.5% of all urinary stones. In women, these types were found at ages 51–70. In men, the most common type was anhydrous uric acid + sodium urate (8 cases), occurring equally in all age groups above 31 years. One stone comprised anhydrous uric acid + ammonium urate (age 41–50). Calcium oxalate combined with uric acid and urate salts in two- and multi-component stones was observed in 99 cases, predominantly in men (58 cases). Overall, calcium oxalate with uric acid and its salts in various combinations accounted for 10.03%.
Conclusion. A study of regional stone-forming patterns is essential for planning healthcare at both national and regional level. The prevalence of uric acid stones underscores the need for widespread implementation of oral dissolution therapy and effective metaphylaxis for uric acid urolithiasis. The frequent co-occurrence of calcium oxalate with uric acid warrants comprehensive metabolic evaluation of patients with pure uric acid stones and mixed uric acid/urate stones. Identifying concomitant metabolic disorders in patients with predominately uric acid stones requires tailored urinary pH targets during oral dissolution therapy to minimize conditions favoring precipitation of uric acid salts and phosphate crystallization.



Analysis of expression of MGP, UMOD, SPP1, F2, FN1, HAVCR1 genes associated with the development of urolithiasis
Abstract
Introduction. Improving molecular genetic methods for diagnosing polygenic forms of urolithiasis is an urgent task in urology.
Aim. To study the relative expression level of the MGP, UMOD, SPP1, F2, FN1, HAVCR1 genes associated with the development of urolithiasis and the number of proteins encoded by them (Gla protein, prothrombin, fibronectin, osteopontin, uromodulin and TIM-1 protein) in patients with urolithiasis.
Material and methods. Forty-nine people were examined, including 45 patients with urolithiasis and 4 people from the control group, with the average age was 67±12 years. Healthy volunteers served as controls. mRNA was isolated from peripheral venous blood. It was reverse-transcribed into cDNA, and the relative expression levels of the target genes were quantified by RT-PCR.
Results. According to the level of expression of the genes MGP, UMOD, SPP1, F2, FN1, HAVCR1 in the blood, clear hiatuses were identified between the values in the control group and in those with urolithiasis, while no differences were found in the quantitative content of their protein products, either in the blood or urine.
Conclusion. In the blood, with a relative level of expression of the gene MGP above 10%, F2 above 0.5%, FN1 above 0.2%, UMOD above 0.04%, SPP1 above 0.001%, HAVCR1 above 0.01%, urolithiasis can be predicted. The specified levels of expression of the genes MGP, UMOD, SPP1, F2, FN1, HAVCR1 in the blood allow reliable identification of patients with urolithiasis in comparison with the quantitative content of protein products of these genes in the blood and urine.



Andrology
Effects of testis polypeptides on sperm parameters and sperm DNA fragmentation index in patients with male infertility
Abstract
Aim. To evaluate the effect of a drug based on bovine testicular polypeptides (Testiwell) on sperm parameters and sperm DNA fragmentation index in patients with idiopathic male infertility.
Materials and methods. A total of 100 men with a diagnosis of infertility were included in the study. They received Testiwell intramuscularly once a week for 10 weeks. Before and after treatment, basic sperm parameters according to WHO criteria and sperm DNA fragmentation index using the TUNEL method were assessed. Statistical analysis included Shapiro-Wilk, Wilcoxon, paired Student's t-test, and McNemar's test.
Results. The median age of patients was 32 years. Significant improvement was noted in the proportion of morphologically normal sperm (p<0.001), concentration of morphologically normal sperm (from 1.16 to 1.55 million/ml, p=0.048). A decrease in sperm DNA fragmentation index was observed (from 20.8% to 17.8%, p<0.001), a reduction in the frequency of oligozoospermia from 34% to 22% (p=0.0047), and a decrease in the proportion of patients with increased DNA fragmentation index from 79% to 67% (p=0.0013). In patients with oligozoospermia at baseline, the median increase in concentration was 142%, while in those with asthenozoospermia an increase in motility by 77% was seen, and in men with high levels of DNA fragmentation, a decrease in DNA fragmentation index by 15.5% was found.
Discussion. Testiwell demonstrated the ability to positively influence not only quantitative but also qualitative sperm parameters, including morphology and sperm DNA fragmentation. Proposed mechanisms of action include regulation of protamination, reduction of apoptosis, and immunologically mediated effects on sperm maturation. The obtained data are consistent with previously described effects of polypeptide drugs in preclinical models and expand the possibilities of using the Testiwell for various forms of male infertility, including assisted reproduction techniques failures.
Conclusion. Testiwell significantly improves morphological and molecular parameters of spermatogenesis in patients with male infertility. It can be used both in the basic therapy of idiopathic infertility and, possibly, in cases of miscarriage and inefficiency of assisted reproduction techniques.



Endourology
Clinical and laboratory features of bladder explosion: a rare complication of transurethral prostatic procedures
Abstract
Introduction. Currently, benign prostatic hyperplasia is a highly relevant problem. The main treatment methods are transurethral bipolar resection of the prostate (TURis) or transurethral bipolar enucleation (TUEB). One of the most serious complications during these procedures is bladder explosion.
Aim. To investigate the clinical conditions that create the risk of bladder explosion, to develop a surgical strategy for managing this complication, and to analyze the composition of the gas mixture formed intraoperatively in the bladder during transurethral procedures on the prostate.
Materials and methods. Procedures were performed under spinal anesthesia. The PLASMA system was used for transurethral plasma enucleation and transurethral plasma resection, including a 26 Fr plasma resectoscope (Olympus), and a high-frequency generator ESG-400. Plasma electrodes were used as following: Plasma-Needle for incision, Plasma-TUEB Loop for enucleation, and Plasma-Large Loop for resection. Normal saline was used as the irrigation fluid. TUEB and TURis were performed by standard technique.
At the end of the procedure, the gas sample was aspirated through the inflow channel of the resectoscope using a Jané syringe. Gas composition analysis was carried out by gas chromatography on a GC-2014 chromatograph (Shimadzu, Japan) in a physico-chemical analysis laboratory.
Results. In addition to carbon monoxide and carbon dioxide, methane was detected in the gas sample; this formed an explosive mixture that ignited upon contact with the hot loop of the resectoscope.
Conclusions. Bladder explosion occurs during TUR in patients with large prostates and is independent of equipment settings. Management strategy depends on the size of the bladder rupture. To prevent bladder rupture, continuous evacuation of intravesical gases is required by advancing the resectoscope to the gas pocket and allowing fluid drainage, as well as careful monitoring of electrode activation when working at the bladder neck at the 12 o’clock position, and use of a morcellator to evacuate adenomatous tissue after enucleation.



Incidence and associated factors for incidental prostate cancer following endoscopic enucleation for benign prostate hyperplasia performed by a single urologist
Abstract
Objective: to assess the incidence of incidental prostate cancer and associated factors after endoscopic enucleation of benign prostate hyperplasia performed by single urologist.
Materials and methods: a retrospective study included 753 patients after endoscopic enucleation of benign prostate hyperplasia performed by single urologist with more than 3000 enucleation experience. Bipolar enucleation was performed in 22,2% of cases and thulium fiber enucleation (ThuFLEP) was performed in 77,8% of cases.
Results: incidental prostate cancer after endoscopic enucleation of benign prostate hyperplasia performed by single urologist was detected in 6,7% cases (51 patients): in 8,4% – after bipolar enucleation, in 5.3% – after ThuFLEP (p=0,141). Patients with incidental prostate cancer were older (median age 71,5 years and 67,0 years, respectively, p<0.001), had smaller prostate volume (68,0 cm3 and 83,0 cm3, respectively, p=0,048), had higher PSA density (0,08 ng/ml/cm3 and 0,05 ng/ml/cm3, respectively, p=0,006). Univariable logistic regression analysis revealed that additional factor increasing the chance of incidental prostate cancer after endoscopic enucleation is lower IPSS values (OR=0,948; 95%CI=0,897-0,999; p=0,045). During the ROC analysis for these parameters, it was shown that the quality of the parameters «age» and «PSA density» as predictors of incidental prostate cancer after endoscopic enucleation is average (AUC 0,662 and 0,624, respectively), while the parameters «prostate volume» and «IPSS» are unsatisfactory (AUC 0,584 and 0,555, respectively). The value of 68,5 years was chosen as the cut-off point for the age of patients: if the patient is older, it was predicted a high chance of incidental prostate cancer with sensitivity and specificity of 69,6% and 57,4%, respectively. The value of 0,0543 ng/ml/cm3 was chosen as the cut-off point for PSA density: if the PSA density is higher, it was predicted a high chance of incidental prostate cancer with sensitivity and specificity of 68,2% and 56,1%, respectively.
Conclusions: in the present cohort of patients after endoscopic enucleation for benign prostate hyperplasia, there is a low incidence of incidental prostate cancer (6.7%), which, together with the absence of strong predictors, indicates a full competent examination before planning endoscopic enucleation. Nevertheless, before surgery, it is important to pay attention to such parameters as the older age and higher PSA density associated with a higher chance of incidental prostate cancer.



Clinical case
Robot-assisted vesiculectomy for Zinner syndrome
Abstract
The association of congenital cysts of seminal vesicles with unilateral renal agenesis and obstruction of the vas deferens was first described by A.Zinner in 1914. Later, the combination of these anomalies was called Zinner’s syndrome. Zinner’s syndrome occurs in just over 200 cases out of 100,000 patients and includes a triad of symptoms: cystic formation of the seminal vesicle, obstruction of the vas deferens and ipsilateral renal agenesis. Zinner’s syndrome is most often asymptomatic until the third or fourth decade of life, and symptoms usually appear with the onset of sexual activity. Patients usually have non-specific symptoms such as problems urinating, pain in the perineum, possible hematuria, recurrent urinary tract infections, and painful ejaculation. Infertility caused by obstruction of the vas deferens is also common. The severity of the symptoms is associated with an increase in cyst size. Minimally invasive interventions such as traditional laparoscopy or robot-assisted surgery are safe and effective and should currently be considered the gold standard of treatment. In the framework of this work, we present a clinical case of treatment of a patient with Zinner’s syndrome.



Purple urine bag syndrome and penile high-grade dysplasia: a rare clinical intersection
Abstract
Purple urine bag syndrome (PUBS) is an uncommon phenomenon characterized by the purple discoloration of urinary catheter bags. We present a unique case of an 81-year-old male with a history of acute ischemic stroke, initially presenting with a cauliflower-like growth on the distal part of the penis. Subsequent assessment revealed a high-grade dysplasia lesion. During the preparation for partial penectomy, the patient developed PUBS. Urine culture indicated a mixed growth of organisms, promptly treated with intravenous cefuroxime, resulting in the resolution of the purple discoloration. The patient underwent successful partial penectomy and was discharged without complications. This case highlights the rare co-occurrence of PUBS and high-grade dysplasia, emphasizing the importance of comprehensive management in such complex clinical scenarios.



Literature reviews
Autonomic dysreflexia
Abstract
Autonomous dysreflexia (AD) is a life-threatening condition that occurs in patients with spinal cord injury at the Th6 level and above. As a result of AD, dysregulation of the autonomic nervous system occurs, which leads to an uncoordinated sympathetic reaction, and can result in a potentially life-threatening increase in blood pressure, a hypertensive crisis, and even death. In about 85% of cases of AD, the cause is bladder overdistension. Urologists need to understand the clinical features of this condition and how to help patients with AD.



Assessment of the sensitivity of Eschericia coli to nitrofuran derivatives – an important issue in the context of growing antimicrobial resistance
Abstract
Urinary tract infections (UTIs) are among the most common infectious diseases. Antimicrobial therapy is the main component of UTI therapy. Current recommendations suggest the use of nitrofuran derivatives as first-line drugs for the treatment of uncomplicated UTIs. This group of drugs has the following advantages: slow development of resistance and high activity against E. coli. However, for some nitrofurans, it is impossible to obtain data on the prevalence of resistant strains due to the absence of sensitivity interpretation criteria. This review is devoted to the study of correlation of sensitivity data between class I nitrofuran derivatives and the possibility of comparing the activity of nitrofurantoin and furazidine against E.coli.



Tuberculosis of the urinary bladder: a literature review. Part 1
Abstract
Tuberculosis remains a significant public health issue worldwide. In 2022, over 45 000 new tuberculosis cases were registered in Russia, corresponding to an incidence rate of 31.0 per 100 000 population. Among genitourinary tuberculosis, bladder involvement accounts for 10.6-52.3%. The clinical presentation of tuberculous cystitis mimics that of typical cystitis. Lack of specific symptoms, combined with insufficient clinical suspicion among phthisiatrists, often leads to delayed diagnosis and treatment, so that irreversible morphological changes have occurred in the bladder wall. This process manifests as persistent impairments of both the storage and voiding phases and significantly diminishes quality of life. The so-called small contracted bladder represents the end-stage of bladder involvement and is universally considered an indication for surgical intervention.
A literature search was carried out in Elibrary.ru, PubMed, and Google Scholar to compile data on tuberculous bladder involvement leading to the development of a small, contracted bladder. This review covers the etiology, pathogenesis, and classification of bladder tuberculosis, and summarizes current diagnostic approaches.



Lectures
Review of current methods of diagnosis and treatment of locally advanced urothelial bladder cancer
Abstract
Aggressive disease course, recurrences, and deterioration of patients’ quality of life remain significant challenges in the treatment of bladder cancer. Determining the indications for systemic therapy or radical treatment, the early detection, and the optimal timing for initiating adjuvant therapy are all crucial aspects in the management of urothelial carcinoma. The analysis of the literature on changes in diagnostics and therapeutic approaches to urothelial bladder cancer according to disease stage is presented in the article.



Anniversaries
For the anniversary of Shalikenov Bulat Uahitovich


